BUSINESS NEED. This agreement is to be signed by the Parent/Carer and their child:
BUSINESS NEED. 1.1.1. Identify the core business needs of the framework user market and determine how they will be reflected in framework planning, procurement and operation. Mandatory
BUSINESS NEED. Facilitating an information system that would aid physicians to work closely with their elderly patients would be a novel informatics solution to address this problem. By integrating clinical data as well as activity tracking data among the elderly, the Online Healthy Aging Assistance (OHAA) tracking system would provide primary care physicians with a comprehensive understanding of patient health, enabling them to mitigate the onset of loneliness and improve health outcomes. This system could significantly improve the quality of life for the elderly as well as reduce the mortality rate associated with loneliness.
BUSINESS NEED. The senior population is growing and more and more seniors are choosing to live at home independently. ADEs among seniors constitutes a large portion of the U.S. healthcare cost in hospitalizations and ED visits. Currently, there are mainly passive surveillance system of ADEs and with the FDA Adverse Event Reporting System, it is voluntary and there is no denominator showing the number of patients that took the medication or were prescribed the medication (which can come from EMRs and pharmacies) and it is also unknown as to the percentage of ADEs that are even reported. Currently ADEs are reported voluntarily when there is a hospitalization, ED visit, or fatality. Many of these ADEs amongst seniors with CHF are due to memory loss and taking many pills without assistance or guidance. They may visit many providers who prescribe medications without the knowledge of their existing medications. They may also be taking over the counter medications that the provider is unaware of. Some of the pills that seniors with CHF take can lead to serious ADEs if not taken properly, and these require blood tests. Many of these ADEs are preventable with the right guidance and intervention.
BUSINESS NEED. Billions of dollars are spent annually on the development and conduct of clinical research in the United States alone. Clinical trials, especially phase III trials, have gotten larger and become increasingly more complex with the average length of one trial increasing by 70% and the clinical research staff work burden by 67% from 1995 to 2005. This impact is thought to have grown even greater in recent years (Xxxxxx, 2017).The exponential growth in the complexity of conducting clinical research has resulted in the development of niche research systems used to meet a variety of clinical and administrative research needs. These siloed systems often hinder organizational workflow by requiring transcription of data across multiple databases, threatening data quality, and extending research timelines by requiring prolonged data cleanup periods. Such a duplicative data entry process also detracts from clinical duties and productivity. A solution to addressing these issues is needed.
